Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Sep 24 | RLMD Relmada Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.95 | 24,120 | 71.15 k | 88,335 |
10 Sep 24 | RLMD Relmada Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.73 | 21,118 | 57.65 k | 64,215 |
9 Sep 24 | RLMD Relmada Therapeutics | Common Stock | Buy | Acquire P | No | No | 2.55 | 8,194 | 20.89 k | 43,097 |
24 May 24 | RLMD Relmada Therapeutics | Stock Option Common Stock | Other | Dispose J | No | No | 2.48 | 54,624 | 135.47 k | 82,090 |
24 May 24 | RLMD Relmada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.48 | 54,624 | 135.47 k | 136,714 |
31 Jan 24 | RLMD Relmada Therapeutics | Common Stock | Buy | Acquire P | No | No | 4.0645 | 6,875 | 27.94 k | 34,903 |
30 Jan 24 | RLMD Relmada Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.8882 | 15,000 | 58.32 k | 28,028 |
29 Jan 24 | RLMD Relmada Therapeutics | Common Stock | Buy | Acquire P | No | No | 3.6528 | 10,800 | 39.45 k | 13,028 |
15 Dec 23 | RLMD Relmada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.48 | 82,090 | 203.58 k | 82,090 |
25 May 23 | RLMD Relmada Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.37 | 317,643 | 1.07 mm | 512,560 |